Search Dental Tribune

How open architecture CAD/CAM can benefit your practice

With exocad’s ChairsideCAD, clinicians have the freedom to choose the best hardware and software for same-day dentistry regardless of the product or system they prefer. The technology has been selected as a Cellerant Best of Class Technology Award recipient in 2019 and 2020. (Photo: exocad)

Tue. 13 April 2021

save

ChairsideCAD, available from exocad, is the choice of software for leading manufacturers of dental CAD/CAM systems, according to the company, and it has been selected as a Cellerant Best of Class Technology Award recipient in 2019 and 2020.

“We are entering a new era in dentistry — one that will change how we diagnose, treat and manage our patients and practices,” said Dr. Lou Shuman, CEO of Cellerant and founder of the Best of Class Technology Awards. “This was a breakthrough year in product and services technologies. The panel spent hundreds of hours in close discussion reviewing and analyzing the corporate landscape. Pay close attention to our winners as they are truly leading the way to provide you what is best in today’s contemporary practice.”

With exocad’s ChairsideCAD, clinicians have the freedom to choose the best hardware and software for same-day dentistry regardless of the product or system they prefer. This is a groundbreaking evolution, according to the company, since historically the industry has been limited to specific workflows and specific hardware/software working together and adhering to a more closed architecture.

Derived from exocad DentalCAD, a signature software solution within the dental laboratory marketplace for more than a decade, ChairsideCAD includes dentalshare, a powerful collaboration tool for clinicians and labs, according to the company.

“We are honored to receive this prestigious industry award from our clinical audience. With exocad ChairsideCAD, clinicians can access labs, design and production centers with freedom of choice,” said Larry Bodony, president of exocad America. “With this open and flexible workflow, clinicians can maximize their return on investment as well as valuable chair time.”

“Our goal is to help the doctor make the best decisions for their office, which, in the end, benefits the patients that we all serve,” said John Flucke, DDS, Best of Class panel member. “I’m honored to be able to help my peers with the decision-making process and helping them wade through the plethora of high-tech products that can change offices and lives for the better.”

Bodony said, “Having received the Best of Class Award from the Cellerant Company and recognition from their exclusive panel of experts is truly an honor.”

(Source: exocad)

Tags:
To post a reply please login or register

Predictable longevity of dental implants: high-quality evidence support

Literature shows predictable longevity of dental implants with long-term bone stability. (Image: Canva)

Tue. 21 October 2025

save

MUMBAI, India: For decades, the central question surrounding dental implantology has been one of longevity. Clinicians and patients alike have sought assurance that this significant investment in oral health would stand the test of time. A comprehensive analysis of long-term clinical data from high-impact factor journals, spanning 20 to 40 years, provides a definitive answer: dental implants offer exceptional, predictable long-term survival and success, but this durability is fundamentally tied to a systematic commitment to supportive therapy.

A consolidation of evidence from peer-reviewed systematic reviews and meta-analyses demonstrates that the long-term viability of dental implants is no longer in question. Contemporary data reveal implant survival rates ranging from 88% to an impressive 95% at the 20- to 25-year mark. Even more remarkably, ultra-long-term studies tracking implants for over 30 and even up to 40 years report survival rates exceeding 95%. This confirms that modern titanium implants are engineered for a lifetime of function.

Stability of peri-implant bone

One of the most compelling findings is the long-term stability of peri-implant bone. Across multiple studies, marginal bone loss is consistently minimal, typically measuring less than 2 mm over two decades. The data also present a clear pattern of failure: the vast majority of implant losses occur within the first three years of service, after which the survival remains steady. Implants that successfully integrate and navigate this initial period demonstrate exceptional stability thereafter, making early-phase monitoring critical and long-term outcomes highly predictable.

Peri-implant diseases

While implant survival is high, the prevalence of peri-implant diseases from meta-analyses indicates that while nearly two-thirds of patients may experience peri-implant mucositis, the progression to destructive peri-implantitis is far from inevitable. Long-term studies place the incidence of peri-implantitis between 7% and 30% over 25 years.

However, these figures are dramatically influenced by patient compliance. One landmark 40-year follow-up study reported zero cases of peri-implantitis, underscoring a crucial point: biological complications are largely manageable, and often preventable, through diligent professional maintenance.

Long-term supportive care

The evidence unequivocally identifies systematic Supportive Implant Therapy (SIT) as the single most critical factor in ensuring long-term success. A 25-year study by Frisch et al. found that 60% of implants in SIT-compliant patients showed no signs of peri-implantitis over the entire period.

The contrast with non-compliance is stark, particularly for patients with a history of periodontitis. Data shows that periodontally compromised patients who fail to adhere to a supportive care regimen face an odds ratio of 14.59 for implant loss. This transforms SIT from a mere recommendation into an essential, non-negotiable component of the implant treatment continuum. While risk factors such as smoking, diabetes, and a history of periodontitis are significant, their impact can be profoundly mitigated by a robust maintenance protocol.

Conclusion

The data is clear: a high success rate in the long-term can be ensured with years of diligent follow-up & supportive care. Prosthetic components will require maintenance and eventual replacement, but the implant fixture itself is capable of outlasting the patient.

This body of evidence calls for a clinical paradigm shift. The conversation with patients must evolve to frame implant therapy as a lifelong partnership. The true measure of success is not just a well-integrated implant, but healthy peri-implant bone and soft tissues all around and a healthy, functional restoration decades later. This can only be achieved when systematic, supportive care is considered as integral to the treatment plan as the implant itself.

More details and references can be found here

Editorial note:

The long-term data collected was published as a pre-print on ResearchGate by Dr Rajeev Chitguppi. It can be accessed here

Topics:
Tags:
To post a reply please login or register
advertisement